Agarose Bead Technologies (ABT) has expanded its facility in Burgos, Spain, about 250 km north of Madrid. In addition to the four existing cleanrooms, this 1000 square-meters expansion includes two ...

Jared Auclair, Director, ICH Q1 Stability Training Center, Biopharmaceutical Analysis & Training Lab (BATL) and Adjunct Professor, Northeastern University and NIBRT (Worcester, MA) ...

Articles In Color Color reprints are printed on 70# enamel paper and can be reproduced in color or in black and white. Color articles reprinted in black and white will be charged black and white ...

This website (the “Site”) is operated by Informa Connect, a trading division of the Informa Group. The parent company of the Informa Group is Informa PLC. Informa Connect (“Informa Connect”, “we” or ...

The buildout of its $1.5 billion facility will establish the Anglo-Swedish drugmaker’s first manufacturing presence in Singapore. Additionally, it will be AstraZeneca’s first ADC plant to produce the ...

Bionova’s 2,000 L scale facility in Fremont, California marks a full transition to a contract development and manufacturing organization (CDMO) for the bioservices firm. In July 2020, Bionova broke ...

Protein A has made monoclonal antibodies (MAbs) highly manufacturable and easier to develop in laboratories. Its use has enabled purification platform approaches, which have been key elements in ...

In 2021, Fujifilm began constructing a biomanufacturing site in Holly Springs, North Carolina at a cost of ¥200 billion (then $2 billion, now $1.3 billion) for its contract development manufacturing ...

Founded in the middle of 2002, BPI published its first issue in January of 2003. Our 20th-anniversary issue thus takes the form of a state-of-the-early-21st-century industry report. Assembling this ...

In a Series A financing round led by founding investor Versant Ventures, obesity drug developer SixPeaks has secured $30 million in funding. Beyond this, Anglo-Swedish pharma giant AstraZeneca will ...

Sanofi will build a €1 billion ($1.1 billion) mAb production facility in Vitry-sur-Seine, while it invests €100 million to bolster capacity at its Le Trait site in Normandy and invests €10 million at ...

With this issue, we bid a reluctant farewell to our managing editor as she retires. Cheryl and I have known her and appreciated her friendship for 26 years. Her accumulated knowledge of cell and gene ...